This is a demo store. No orders will be fulfilled.

Sotrovimab (anti-Spike RBD) - Primary antibody, specific to Spike RBD, >95% (SDS-PAGE&SEC), high purity, Human IgG1, INHIBITOR of Spike glycoprotein inhibitor, INHIBITOR of Spike glycoprotein inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: SARS-CoV-2
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab182938
Grouped product items
SKU Size
Availability
Price Qty
Ab182938-100μg
100μg
10
$89.90
Ab182938-1mg
1mg
4
$419.90
Ab182938-5mg
5mg
1
$1,089.90
Ab182938-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,749.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Sotrovimab (anti-Spike RBD) - Primary antibody, specific to Spike RBD, >95% (SDS-PAGE&SEC), high purity, Human IgG1, INHIBITOR of Spike glycoprotein inhibitor
Synonyms Spike RBD antibody | Anti-Spike RBD antibody | Anti-Human Spike RBD Recombinant Antibody | Anti-Spike RBD Reference Antibody | SARS-CoV-2 antibody | Anti-SARS-CoV-2 antibody | VIR 7831
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity Spike RBD
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Spike glycoprotein inhibitor
Product Description

Sotrovimab (anti-Spike RBD) is a human IgG1κ pan-sarbecovirus monoclonal antibody (mAb), neutralizes SARS-CoV-2, SARS-CoV-1, and multiple other sarbecoviruses. Sotrovimab (anti-Spike RBD) is developed based on S309, exhibits a long half-life and great bioavailability in the respiratory mucosa. Sotrovimab (anti-Spike RBD) could result in immune-mediated viral clearance and prevent progression of Covid-19 early in the course of disease.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 26.2 kDa (Light Chain) & 51.3 kDa (Heavy Chain), under reducing conditions; 196.4 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95% (SDS-PAGE&SEC)
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 2423014-07-5

Images

Sotrovimab (anti-Spike RBD) (Ab182938) - ELISA
Immobilized Human Spike RBD protein (rp155929) at 1.0 μg/mL can bind Sotrovimab (anti-Spike RBD) (Ab182938) with the EC50 of 41.33 ng/mL.

Sotrovimab (anti-Spike RBD) (Ab182938) - SEC
The purity of Sotrovimab (anti-Spike RBD) (Ab182938) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0505656 Certificate of Analysis May 15, 2024 Ab182938
ZJ24F0505655 Certificate of Analysis May 15, 2024 Ab182938
ZJ24F0505654 Certificate of Analysis May 15, 2024 Ab182938

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.